NEW YORK, NY / ACCESSWIRE / May 25, 2018 / U.S. markets were weighed down by the energy sector on Thursday as U.S. crude oil prices closed lower for the third consecutive session. However, major indexes received a boost after President Trump announced the cancellation of a planned summit with North Korean leader Kim Jong Un. The Dow Jones Industrial Average dropped 0.30 percent to close at 24,811.76, while the S&P 500 Index declined 0.20 percent to close at 2,727.76. The Nasdaq Composite Index fell 0.02 percent to close at 7,424.43.
"The selloff after the cancellation of the North Korea meeting was muted, largely because it doesn't change the second-quarter earnings or economic growth," Karyn Cavanaugh, senior market strategist at Voya Financial. "Geopolitical risks are never fun and markets tend to price in the bad news right away and the good news only gradually," Cavanaugh added.
RDI Initiates Coverage on:
Corcept Therapeutics Inc.
https://rdinvesting.com/news/?ticker=CORT
Verastem, Inc.
https://rdinvesting.com/news/?ticker=VSTM
Corcept Therapeutics' stock moved 3.28% higher Thursday, to close the day at $18.59. The stock recorded a trading volume of 918,638 shares, which was below its three months average volume of 1,323,006 shares. In the last year, Corcept Therapeutics' shares have traded in a range of 10.40 - 25.96. The share price has gained 78.75% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $17.24 is below its 200-day moving average of $17.86. Shares of the company are trading at a Price to Earnings ratio of 17.88. Shares of Corcept Therapeutics have gained roughly 7.21 percent in the past month and are up 2.93 percent year-to-date.
Access RDI's Corcept Therapeutics Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CORT
On Thursday, shares of Verastem recorded a trading volume of 2,507,482 shares, which was above the three months average volume of 1,100,869 shares. The stock ended the day 7.50% higher at 5.73. The share price has gained 198.44% from its 52-week low with a 52-week trading range of 1.92 - 5.80. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $4.30 is greater than its 200-day moving average of $3.57. Shares of Verastem have gained roughly 32.33 percent in the past month and are up 86.64 percent year-to-date.
Access RDI's Verastem, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=VSTM
Our Actionable Research on Corcept Therapeutics Inc. (NASDAQ :CORT) and Verastem, Inc. (NASDAQ :VSTM) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
contact@rdinvesting.com
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
